Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$96,194,054
+$46,953,649 QoQ
Shares Held
2,006,551
+49.8% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#36
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $3,560,811,525 across 15 Drug Manufacturers - General names. NVO ranks #9 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
876,181 | $1,050,917,864 | |
| 2 | JNJ |
Johnson & Johnson
|
1,962,221 | $498,345,267 | |
| 3 | ABBV |
AbbVie Inc.
|
1,561,703 | $392,986,942 | |
| 4 | AZN |
Astrazeneca PLC
|
1,978,508 | $375,164,686 | |
| 5 | NVS |
Novartis AG
|
2,386,527 | $374,016,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,857,628 | $367,205,197 | |
| 7 | AMGN |
Amgen Inc
|
381,869 | $138,282,402 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
954,962 | $120,649,899 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96,194,054 | 2,006,551 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $49,240,405 | 1,339,875 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $135,403,789 | 2,661,238 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $141,806,636 | 2,555,535 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $195,538,560 | 2,833,071 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $202,355,381 | 2,914,104 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $260,125,598 | 3,024,013 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $366,125,484 | 3,074,876 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $427,478,607 | 2,994,806 | Shares | Other | 2024-08-01 | |
| 2024-03-31 | $384,424,463 | 2,993,960 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $315,771,399 | 3,052,406 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $272,553,818 | 2,997,073 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $247,208,918 | 1,527,584 | Shares | Other | 2023-08-15 | |
| 2023-03-31 | $239,601,819 | 1,505,604 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $197,369,976 | 1,458,327 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $147,842,948 | 1,483,920 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $156,940,462 | 1,408,422 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $133,901,535 | 1,205,777 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $113,687,168 | 1,015,064 | Shares | Other | 2022-02-08 | |
| 2021-09-30 | $123,838,690 | 1,289,852 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $81,781,886 | 976,267 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $67,050,740 | 994,523 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $64,904,130 | 929,193 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $72,869,492 | 1,049,539 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $70,325,323 | 1,073,997 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $91,120,044 | 1,513,622 | Shares | Other | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||